These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21508854

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Psychopharmacology of autism spectrum disorders.
    Kaplan G, McCracken JT.
    Pediatr Clin North Am; 2012 Feb; 59(1):175-87, xii. PubMed ID: 22284801
    [Abstract] [Full Text] [Related]

  • 23. A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder.
    Gor RA, Fuhrer J, Schober JM.
    J Pediatr Urol; 2012 Jun; 8(3):314-7. PubMed ID: 21131234
    [Abstract] [Full Text] [Related]

  • 24. Using antipsychotics for behavioral problems in children.
    Shafiq S, Pringsheim T.
    Expert Opin Pharmacother; 2018 Sep; 19(13):1475-1488. PubMed ID: 30102079
    [Abstract] [Full Text] [Related]

  • 25. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder.
    Demb H, Valicenti-McDermott M, Navarro A, Ayoob KT.
    J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis.
    Sharma A, Shaw SR.
    J Pediatr Health Care; 2012 Oct; 26(4):291-9. PubMed ID: 22726714
    [Abstract] [Full Text] [Related]

  • 27. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS, Barnhill LJ, Davis JM.
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [Abstract] [Full Text] [Related]

  • 28. Psychopharmacologic management of serious behavioral disturbance in ASD.
    Stigler KA.
    Child Adolesc Psychiatr Clin N Am; 2014 Jan; 23(1):73-82. PubMed ID: 24231168
    [Abstract] [Full Text] [Related]

  • 29. An update on pharmacotherapy for autism spectrum disorder in children and adolescents.
    Ji N, Findling RL.
    Curr Opin Psychiatry; 2015 Mar; 28(2):91-101. PubMed ID: 25602248
    [Abstract] [Full Text] [Related]

  • 30. Risperidone in the management of disruptive behavior disorders.
    Pandina GJ, Aman MG, Findling RL.
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):379-92. PubMed ID: 16958564
    [Abstract] [Full Text] [Related]

  • 31. Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder.
    Dinnissen M, Dietrich A, van den Hoofdakker BJ, Hoekstra PJ.
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):111-24. PubMed ID: 25385293
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of medication combined with intensive behavioral intervention for reducing aggression in youth with autism spectrum disorder.
    Frazier TW, Youngstrom EA, Haycook T, Sinoff A, Dimitriou F, Knapp J, Sinclair L.
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):167-77. PubMed ID: 20578929
    [Abstract] [Full Text] [Related]

  • 33. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ.
    Aman M, Buitelaar J, Smedt GD, Wapenaar R, Binder C.
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):220-32. PubMed ID: 15910206
    [Abstract] [Full Text] [Related]

  • 34. [Pediatric psychiatry: children and antipsychotic drugs: clinical monitoring by the nurse assures a safe course in children taking antipsychotic drugs].
    Fournier A, Laflamme F.
    Perspect Infirm; 2010 Apr; 7(5):19-21. PubMed ID: 21744626
    [No Abstract] [Full Text] [Related]

  • 35. Clozapine and Electroconvulsive Therapy Is an Effective and Safe Treatment During Pregnancy: A Case Report.
    Molins C, Fortea A, Bioque M, Solé E, Parellada E.
    J ECT; 2019 Sep; 35(3):e30-e32. PubMed ID: 31232910
    [No Abstract] [Full Text] [Related]

  • 36. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.
    Nielsen J, Kane JM, Correll CU.
    Bipolar Disord; 2012 Dec; 14(8):863-9. PubMed ID: 23107278
    [Abstract] [Full Text] [Related]

  • 37. Care of the patient with an autism spectrum disorder by the general physician.
    Venkat A, Jauch E, Russell WS, Crist CR, Farrell R.
    Postgrad Med J; 2012 Aug; 88(1042):472-81. PubMed ID: 22427366
    [Abstract] [Full Text] [Related]

  • 38. A retrospective review of the effectiveness of aripiprazole in the treatment of sensory abnormalities in autism.
    Fung LK, Chahal L, Libove RA, Bivas R, Hardan AY.
    J Child Adolesc Psychopharmacol; 2012 Jun; 22(3):245-8. PubMed ID: 22537360
    [Abstract] [Full Text] [Related]

  • 39. Effects of topiramate on aggressive, self-injurious, and disruptive/destructive behaviors in the intellectually disabled: an open-label retrospective study.
    Janowsky DS, Kraus JE, Barnhill J, Elamir B, Davis JM.
    J Clin Psychopharmacol; 2003 Oct; 23(5):500-4. PubMed ID: 14520128
    [Abstract] [Full Text] [Related]

  • 40. Psychopharmacological interventions in autism spectrum disorder.
    Politte LC, Henry CA, McDougle CJ.
    Harv Rev Psychiatry; 2014 Oct; 22(2):76-92. PubMed ID: 24614763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.